Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recurrence
×
brexucabtagene autoleucel
×
90 days
×
Clear all
Filters
3
NCT02625480
2026-04-09
ZUMA-4
Gilead Sciences
Phase 1/2
Completed
95 enrolled
NCT05537766
2026-03-10
ZUMA-25
Gilead Sciences
Phase 2
Terminated
19 enrolled
28 charts